Ziedonis PUBLICATIONS:

Summary: 345 publications / scholarly works:  

With 158 original research articles, 3 major reviews (NIH, IOM, RCP), 6 practice guidelines, 37 review articles, 1 letter, 24 invited articles, 9 books, 46 chapters, 20 behavioral therapy manuals, 12 organizational change & leadership development manuals, 25 refereed published conference proceedings (NIDA Research Monograph Series & Journals), 1 CD, 2 computer programs, and 1 video 

Original Research Articles:

1.     Townsend, J.B., Ziedonis, D.M., Bryan, R.M., Brennan, R.W., and Page, R. Choroid Plexus Blood Flow: Evidence of Dopaminergic Control.  Journal of Cerebral Blood Flow and Metabolism 3:216-7, 1983.

 2.     Townsend, J.B., Ziedonis, D.M., Bryan, R.M., Brennan, R.W., and Page, R. B. Choroid Plexus Blood Flow: Evidence for Dopaminergic Influence. Brain Research 290:165-9, 1984.

 3.     Ziedonis, D.M., Servers, W.B., Brennan, R.W., and Page, R.B.  Blood Flow and Functional Responses Correlate in the Ovine Neural Lobe.  Brain Research 373:27-34, 1986.

 4.     Ziedonis, D.M., Ungerleider, J.T., and Noble, E.P.  Teaching Substance Abuse Using an Interactive Teaching Model.  Substance Abuse 10(2):97-102, 1989.

 5.     Ziedonis, D.M. and Kosten, T.R. Depression as a Prognostic Factor for Pharmacological Treatment of Cocaine Dependence.  Psychopharmacology Bulletin 27:337-343, 1991.

 6.     Ziedonis, D.M. and Kosten, T.R.  Pharmacotherapy Improves Treatment Outcome In Depressed Cocaine Addicts.  Journal of Psychoactive Drugs 23(4):417-425, 1991.

 7.     Kosten, T.R., Rosen, M., Schottenfeld, R., and Ziedonis, D.M. Buprenorphine for Cocaine and Opiate Dependence.  Psychopharmacology Bulletin 28(1):15-19, 1992.

 8.     Jenkins, S.W., Warfield, N.A., Blaine, J.D., Cornish, J., Ling, W., Rosen, M., Urschel, H., Wesson, D., and Ziedonis, D.M.  A Pilot Trial of Gepirone versus Placebo in the Treatment of Cocaine Dependence. Psychopharmacology Bulletin 28(1), 1992.

 9.     Ziedonis, D.M., Richardson, R., Lee, E., Petrakis, I., and Kosten, T.  Adjunctive Desipramine in the Treatment of Cocaine Abusing Schizophrenics. Psychopharmacology Bulletin 28(3):309-314, 1992.

 10.  Ungerleider, J.T, Pechnick R., Wallbom, A.S., Siegal, N., Fairbanks, L., Ziedonis, D.M.  Interactive Teaching, Medical Students and Substance Abuse: University and Community Join Together in New Endeavor. Academic Psychiatry 16(3):160-169, 1992.

 11.  Carroll, K., Ziedonis, D.M. O'Malley, S., McCance-Katz E, Gordon, L., and Rounsaville, B.J.  Pharmacological Interventions for Abusers of Alcohol and Cocaine:  Disulfiram versus Naltrexone.  The American Journal on Addictions 2(1): 77-79, 1993.

.12.  Schottenfeld, R.S., Pakes, J.R., Ziedonis, D.M., and Kosten, T.R. Buprenorphine: Dose-Related Effects on Cocaine and Opioid Use in Cocaine Abusing Opioid-Dependent Humans.  Biological Psychiatry 34:66-74, 1993.

13.  Kosten, T.R., Schottenfeld, R., Ziedonis, D.M., and Falcioni, J. Buprenorphine versus Methadone Maintenance for Opioid Dependence. Journal of Nervous and Mental Disease 181:358-364, 1993.

 14.  Oliveto, A., Kosten, T.R., Schottenfeld, R.S., and Ziedonis, D.M.  Cocaine Abuse Among Methadone-Maintained Patients.  American Journal of Psychiatry 150:1755, 1993.

 15.  Ziedonis, D.M., Rayford, B.S., Bryant, K., and Rounsaville, B.J.   Psychiatric Comorbidity in White and African-American Cocaine Addicts Seeking Substance Abuse Treatment.  Hospital and Community Psychiatry 45:43-49, 1994.

 16.  Oliveto, A., Kosten, T.R., Schottenfeld, R., Ziedonis, D.M., and Falcioni, J. Cocaine Use in Buprenorphine versus Methadone Maintained Patients. American Journal of Addictions 3:43-48, 1994.

 17.  Ziedonis, D.M., Kosten, T.R., Glazer, W.M., and Frances, R.J.  Nicotine Dependence and Schizophrenia.  Hospital and Community Psychiatry 45:204-206, 1994.

 18.  Leal, J., Ziedonis, D.M., and Kosten, T.R.  Antisocial Personality Disorder as a Prognostic Factor for Pharmacotherapy of Cocaine Dependence. Drug and Alcohol Dependence 35:31-35, 1994.

 19.  George, T., Sernyak, M.J., Ziedonis, D.M., and Woods, S.W.  Effects of Clozapine on Smoking In Chronic Schizophrenic Outpatients.  Journal of Clinical Psychiatry 56:344-346, 1995.

 20.  Farren, C.K., Ziedonis, D.M., Clare, A.W., Hameedi, F.A., and Dinan, T.G.  D-Flenfluramine induced prolactin response in post-withdrawal Alcoholics and Controls. Alcoholism: Clinical and Experimental Research 19:1578-1582, 1995.

 21.  Farren, C.K., Clare, A.W., Ziedonis, D.M., Hammeedi, F.A., and Dinan, T.G. Evidence for reduced dopamine D2 receptor sensitivity in post-withdrawal alcoholics. Alcoholism: Clinical and Experimental Research 19:1520-1524. 1995.

 22.  Oliveto, A., Kosten, T., Schottenfeld, R., Falcioni, J., and Ziedonis, D.M.  Desipramine, Amantadine, or Fluoxetine in Buprenorphine Maintained Cocaine Users.  Journal of Substance Abuse Treatment 12:423-428, 1995.

 23.  Schottenfeld, R.S., Pakes, J., Ziedonis, D.M., and Kosten, T.R. Buprenorphine: Dose-Related Effects on Cocaine and Opioid Use in Cocaine Abusing Opioid-Dependent Humans.  Yearbook of Psychiatry and Applied Mental Health, 5:160-161, 1995

 24.  Ziedonis, D.M. and Kosten, T.R.  Nicotine Dependence and Schizophrenia.  Italian Journal of the Addictions 4:44-47, 1996.

 25.  Ziedonis, D.M. and George, T.P.  Schizophrenia and Nicotine Use:  Report of a Pilot Smoking Cessation Program and Review of Neurobiological and Clinical Issues.  Schizophrenia Bulletin 23(2):247-254, 1997.

 26.  Ziedonis, D.M. and Trudeau, K.  Motivation to Quit Using Substances Among Individuals With Schizophrenia:  Implications for a Motivation-Based Treatment Model.  Schizophrenia Bulletin 23(2):229-238, 1997.

 27.  Schottenfeld, R.S., Pakes, J.R., Oliveto, A., Ziedonis, D.M., and Kosten, T.R.  Buprenorphine versus Methadone Maintenance For Concurrent Opioid Dependence and Cocaine Abuse.  Archives of General Psychiatry 54(8):713-720, 1997.

 28.  Kraus, M.L., Ziedonis, D.M., Feinberg, M.A., Segal, S.R., Israel, L., and Kraus, M.  A Community Hospital’s Ambulatory Addiction Medicine Program.  Connecticut Medicine 62:89-93, 1998.

 29.  Smelson, D.A., Roy, M., Roy, A., Engelhart, C., Williams, J., and Ziedonis, D. Relationship between Electroretinogram, Blue Cone Amplitude, and Cue Elicited Cocaine Craving.  In L. Harris (Ed), Problems of Drug dependence, 1999.  National Institute on Drug Abuse Research Monograph.   Washington DC: USGPO, 2000.  

 30.  Woods, S., Ziedonis, D.M., Sernak, M., Diaz E., and Rosenheck R.  Characteristics of Participants and Non-participants in Medication Trials for Treatment of Schizophrenia.  Psychiatric Services 51:79-84, 2000.

 31.  George, T.P., Ziedonis D.M., Feingold A., Pepper W.T., Satterburg C.A., Winkel J., Rounsaville B.J., and Kosten T.R.  Nicotine Transdermal Patch and Atypical Antipsychotic Drugs for Smoking Cessation in Schizophrenia.  American Journal of Psychiatry 157 (11):1835-1842, 2000.

 32.  Carol, G., Smelson, D., Losonczy, M.F., Ziedonis, D. A preliminary investigation of cocaine craving among persons with and without schizophrenia.  Psychiatric Services 52:1029-1031, 2001.

 33.  Ziedonis, D. and Stern, R. Dual Recovery Therapy for Schizophrenia and Substance Abuse. Psychiatric Annals 31(4):255–264, 2001.

 34.  Smelson, D.A., Davis, C.W., DiPano, R., Johnson, V., Losonczy, M.F., Ziedonis, D.M. Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. Journal of Nervous Mental Disorders 190(3):200-202, 2002.

 35.  Smelson, D.A., Losonczy, M., Kaune, M., Williams, J., Davis, C., Ziedonis, D.M.   Risperidone decreases cue-elicited craving and relapses in withdrawn cocaine-dependent schizophrenics.  Schizophrenia Research 53:160, 2002.

 36.  Roeloffs, C., Wells, K., Ziedonis, D.M., Tang, L., Unutzer J. Problem substance use among depressed patients in managed primary care.  Psychosomatics 43(5):405-12, 2002.

 37.  Smelson, D.A., Losonczy, M.F., Davis, C.W., Kaune, M., Williams J., Ziedonis, D.  Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence.  Canadian Journal of Psychiatry 47(7):671-5, 2002.

 38.  Smelson, D.A., Starosta A., Losonczy M.F., Kind J., Williams J., and Ziedonis D.  An Analysis of Cue Reactivity Among Individuals With Schizophrenia Compared to Cocaine Addicts Without Schizophrenia.  Psychiatric Services 53:1612-1616, 2002.  

 39.  Krejci, J., Steinberg, M.L., and Ziedonis, D.M.  Smoking status and substance abuse severity in a residential treatment sample. Drug and Alcohol Dependence 72, 249-254, 2003.

40.  Smelson, D.A., Davis, C., Eisenstein, N., Engelhart, C., Williams, J., Losonczy., M.F. and Ziedonis, D.M. Cognitive disparity in schizophrenics with and without cocaine dependency. Journal of Substance Abuse Treatment 24(1) 75-79, 2003.

 41.  Williams, J.M. and Ziedonis, D.  Naltrexone-bupropion combination therapy for protracted abstinence dysphoria. The American Journal on Addictions 2(3):270-272, 2003.

 42.  Kampov-Polevoy, A.B., Ziedonis, D.M., Steinberg, M.L., Pinsky, I., Krejci, J.A., Eick, C., Boland, G., Khalitov, E., and Crews, F.T. Association between sweet preference and paternal history of alcoholism in psychiatric and substance abuse patients.  Alcoholism: Clinical and Experimental Research 27(12):1929-1936, 2003.

 43.  Smelson, D.A., Ziedonis, D.M., Losonczy, M.F., Williams, J., and Kaune, M. A double-blind study comparing olanzapine to haloperidol for reducing cue-elicited craving in individuals with schizophrenia and cocaine dependence. Schizophrenia Research 60(1):303, 2003.  

44.  Steinberg, M.L., Ziedonis, D.M., Krejci, J.A., and Brandon, T.H.  Motivational Interviewing With Personalized Feedback: A Brief Intervention for Motivating Smokers with Schizophrenia To Seek Treatment for Tobacco Dependence.  Journal of Consulting and Clinical Psychology 72(4):723-728, 2004.

 45.  Williams, J.M., Ziedonis, D.M., Foulds, J. Case Series of Nicotine Nasal Spray in the Combination Treatment of Tobacco Dependence among Patients with Schizophrenia. Psychiatric Services 55(9):1064-1066, 2004.

 46.  Smelson, D.A., Williams, J., Ziedonis, D.M., Sussner, B.D., Losonczy, M.F., Engelhart, C., and Kaune, M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. Journal of Substance Abuse Treatment 27:45-49, 2004. 

 47.  Steinberg, M.L., Williams, J.M., and Ziedonis, D.M.  Financial Implications of Cigarette Smoking Among Individuals with Schizophrenia.  Tobacco Control 13(2):206, 2004. 

48.  Amass, L., Ling, W., Freese, T.E., Reiber, C., Annon, J.J., Cohen, A.J., McCarty, D., Reid, M., Brown, L.S., Clark, C., Ziedonis, D.M., Krejci, J., Stine, S., Winhusen, T., Brigham, G., Babcock, D., Muir, J., Buchan, B., Horton T. Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience. American Journal on Addictions 13:S42-S66, 2004.

 49.  Steinberg, M.L., Williams, J.M., Steinberg, H.R., Krejci, J.A., Ziedonis, D.M.  Applicability of the Fagerström Test for Nicotine Dependence in Smokers with Schizophrenia.  Addictive Behaviors 30(1):49-59, 2005.

50.  Boudreaux, E.D., Baumann, B.M., Friedman, K., Ziedonis, D.M. Smoking Stage of Change and Interest in an Emergency Department-based Intervention. Academic Emergency Medicine 12(3):211-18, 2005.

 51.  Ling, W., Amass, L., Shoptaw, S., Annon, J.J., Hillhouse, M., Babcock, D., Brigham, G., Harrer, J., Reid, M., Muir, J., Buchan, B., Orr, D., Woody, G., Krejci, J., Ziedonis, D.M. Buprenorphine Study Protocol Group. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction 100(8):1090-100, 2005.

 52.  Williams, J.M., Foulds, J., Dwyer, M., Order-Connors, B., Springer, M., Gadde, P., Ziedonis, D.M.  The Integration of Tobacco Dependence Treatment into Residential Addictions Treatment in New Jersey. Journal of Substance Abuse Treatment 28:331–340, 2005.

 53.  Walters, S.T., Matson, S.A., Baer, J.S., Ziedonis, D.M. Effectiveness of workshop training for psychosocial addiction treatments: A systematic review. Journal Substance Abuse Treatment. 29(4):283-93, 2005.

 54.  Smelson, D.A., Losonczy, M., Castles-Fonseca, K., Stewart, P., Kaune, M., and Ziedonis, D.M. Preliminary Outcomes from a booster case management program for individuals with a co-occurring substance abuse and a persistent psychiatric disorder.  Journal of Dual Diagnosis 13:47–59, 2005.

 55.  Williams, J.M., Ziedonis, D.M., Abanyie, F., Steinberg, M.L., Foulds, J., Benowitz, N.L. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder are not a metabolic effect. Schizophrenia Research 15;79(2-3):323-35, 2005.

 56.  Sussner, B.D., Smelson, D.A., Rodrigues, S., Kline, A., Losonczy, M., Ziedonis, D.M.  The validity and reliability of a brief measure of cocaine craving. Drug and Alcohol Dependence 2006. 27;83(3):233-7.  

 57.  Smelson, D.A., Ziedonis, D.M., Williams, J., Losonczy, M.F., Williams, J., Steinberg, M.L., Kaune, M.  The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clinical Psychopharmacology 26(1):9-12, 2006.

 58.  Hu, H.M., Kline, A., Huang, F.Y., Ziedonis, D.M. Detection of co-occurring mental illness among adult patients in the New Jersey substance abuse treatment system. American Journal of Public Health 96(10):1785-93, 2006.

 59.  Foulds, J., Williams J, Order-Connors, B., Edwards N., Dwyer, M., Kline A., Ziedonis, D.M.  Integrating tobacco dependence treatment and tobacco-free standards into addiction treatment:  New Jersey’s experience.  Alcohol Research Health 29(3):236-240, 2006.

 60.  Steinberg, M.L., Krejci, J.A., Collett, K., Brandon, T.H., Ziedonis, D.M., Chen, K. Relationship between self-reported task persistence and history of quitting smoking, plans for quitting smoking, and current smoking status in adolescents. Addictive Behavior. 32(7)1451-1460, 2007.

 61.  Fuller, B.E., Guydish, J., Tsoh, J., Reid, M.S., Resnick, M., Zammarelli, L., Ziedonis, D.M., Sears, C., McCarty, D. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. Journal Substance Abuse Treatment 32(1):53-60, 2007.

 62.  Gerwe, C.F. and Ziedonis, D.M. Using the Orchestration Group Process of the Gerwe-Orchestration Method in Group Therapy for Addiction and Recovery.  Journal of Groups in Addiction and Recovery 2(1): 41-66 2007.

 63.  Epstein, E.E., McCrady, B., Morgan, T.J., Cook, S.M., Kugler, G., Ziedonis, D.M. The Successive Cohort Design: A Model for Developing New Behavioral Therapies for Drug Use Disorders and Application to Behavioral Couple Treatment. Addictive Disorders and Their Treatment, 6(1):1-19, 2007.

 64.  Epstein, E.E., McCrady, B., Morgan, T.J., Cook, S.M., Kugler, G., Ziedonis, D.M. Couples Treatment for Drug Dependent Males: Preliminary Efficacy of a Stand Alone Outpatient Model.  Addictive Disorders and Their Treatment, 6(1):21-37, 2007.

 65.  Smelson, D.A., Losonczy, M.F., Ziedonis, D.M., Sussner, B.D., Castles-Fonseca, K., Rodrigues, S., and Kline, S. A brief community linkage intervention for veterans with a persistent mental illness and a co-occurring substance abuse disorder.  European Journal of Psychiatry 21(2), 143-152, 2007.

 66.  Kim S.S., Ziedonis, D., Chen, K.  Tobacco Use and Dependence in Asian American and Pacific Islander Adolescents:  A Review of the Literature.  Journal of Ethnicity in Substance Abuse.  6(3/4):113-142, 2007.

 67.  Ziedonis, D.M, Zammarelli, L., Seward, G., Oliver, K., Guydish, J., Hobart, M., Meltzer, B.  Addressing Tobacco Use Through Organizational Change:  A Case Study of an Addiction Treatment Organization.  Journal of Psychoactive Drugs, 39 (4), 451-459, 2007.

 68.  Williams, J.M., Gandhi, K.K., Steinberg, M.L., Foulds, J., Ziedonis, D.M., Benowitz, N.L.  Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia.  Nicotine & Tobacco Research, 9 (8), 873-881, 2007.

 69.  Boudreaux, E.D., Baumann, B.M., Camargo, C.A., Jr., O’Hea, E.L., Ziedonis, D.M.  Changes in smoking associated with an acute health event:  Theoretical and practical implications.  Annals of Behavioral Medicine, 33:189-199, 2007. 

 70.  Huang, F.Y., Ziedonis, D.M., Hu, H.M., and Kline, A. Using Information Technology to Evaluate the Detection of Co-Occurring Substance Use Disorders Amongst Patients in a State Mental Health System: Implications for Co-Occurring Disorder State Initiatives, Community Mental Health Journal 44:11-27, 2008.

 71.  Ross, S., Cidambi, I., Dermatis, H., Weinstein, J., Ziedonis, D.M., Roth, S., Galanter, M. Music Therapy: A Novel Motivational Approach for Dually Diagnosed Patients.  Journal of Addictive Diseases, 27:(1) 41-53, 2008

 72.  Kim, S., Kwon, M-S., Klessig, Y.C., and Ziedonis, D.M. Adapting Tobacco Dependence Group Therapy Treatment for Korean Americans: A Case Report of Pilot Treatment Program.  Journal of Groups in Addiction & Recovery Therapy   2008. 3(1-2), 93-108.

 73.  Boudreaux, E.D., Baumann, B.M., Perry, J., Marks, D., Francies S., Camargo, C..A., Jr., Ziedonis, D.M.  Emergency Department Initiated Treatments for Tobacco (EDITT):  A pilot study.  Annals of Behavioral Medicine, 2008. 36(3):314-25. 

 74.  Williams, J.M., Ziedonis, D.M., Vreeland, B., Speelman-Edwards, N., Zechner, Michelle R., Williams, M.T., Rahim, R., Karmi, L., Molnar, M., and Eilers, R.  A Wellness Approach to Addressing Tobacco in Mental Health Settings:  Learning About Healthy Living.  American Journal of Psychiatric Rehabilitation 12:4, 352-369, 2009

 75.  Gonzalez, G., Romero-Gonzalez, M., Desai, R., Randall, M., Patwa, H., Tokuno, H., Petrakis, I., Ziedonis, D. M. Myoclonus Cases Associated with Tiagabine Treatment for Cocaine and Opioid Dependent Patients. American Journal on Addictions; 2009; 18(4):324-324.

 76.  Ziedonis, D.M., Amass, L., Steinberg, M.L., Krejci, J., Woody, G., Annon, J., Cohen, A.J., Waite-O’Brien, N., Stine, S., McCarty, D., Reid, M., Brown, L., Maslansky, R., Winhusen, T., Babcock, D., Brigham, G., Muir, J., Orr, D., Buchan, B.J., Horton, T., and Ling, W.  Predictors of Outcome For Short-Term Medically Supervised Opioid Withdrawal during a Randomized, Multi Center Trial of Buprenorphine-Naloxone and Clonidine in the NIDA Clinical Trials Network Drug and Alcohol Dependence.  Drug & Alcohol Dependence.   2009. 99:28-36.

 77.  Williams, J.M, Steinberg, M.L., Zimmermann, M.H., Gandhi, K.K., Stipelman, B, Budsock, P.D., Ziedonis, D.M.  Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder.  Journal Substance Abuse Treatment.  38(4): 384-93, 2010.  

 78.  Chen, K.W., Comerford, A., Shinnick P., Ziedonis, D.M.  Introducing qigong meditation into residential addiction treatment:  a pilot study where gender makes a difference.  Journal of Alternative Complementary Medicine 2010. 16(8):875-82.

 79.  DiFranza, J., Ursprung, W.W., Lauzon, B., Bancej, C., Wellman, R.J., Ziedonis, D., Kim, S.S., Gervais, A., Meltzer, B., McKay, CE., O'Loughlin, J., Okoli, C.T., Fortuna, L.R., Tremblay, M. A systematic review of the diagnostic and statistical manual diagnostic criteria for nicotine dependence.  Addictive Behaviors.  2010. 35(5):373-82.

 80.  Boudreaux, E.D., Moon, S., Baumann, B.M., Camargo, C.A., Jr., O’Hea, E., Ziedonis, D.M.  Intentions to Quit Smoking:  Causal Attribution.  Perceived Illness Severity, and Event-Related Fear During an Acute Health Event.  Annals of Behavioral Medicine.   2010. 40:350-355.

 81.  Guydish, J., Tajima B., Chan, M., Delucchi, K.L., Ziedonis, D. Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment.  Drug & Alcohol Dependence 2011. 114(2-3):237-41.

 82.  Ozhathil, D., Abar, B., Baumann, B.M., Camargo, C.A., Ziedonis, D., & Boudreaux, E.D. The effect of removing cost as a barrier to treatment initiation with an outpatient tobacco dependence clinic among emergency department patients. Academic Emergency Medicine.  2011. 19(6): 662-664.

 83.  Guydish, J., Ziedonis, D., Tajima, B., Seward, G., Passalacqua, E., Chan, M., Delucchi, K., Zammarelli, L., Levy, M., Kolodziej, M., Brigham, G.  Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings.   Drug & Alcohol Dependence. 2012. 121(1-2):30-7.

 84.  Byatt, N., Biebel, K., Lundquist, R., Moore Simas, T., Debourdes-Jackson, G., Ziedonis, D.  Patient, Provider and System-level Barriers and Facilitators to Addressing Perinatal Depression.  Journal of Reproductive and Infant Psychology.  2012. 30(5): 436-439.

 85.  Guydish, J., Tajima,.B., Kulaga, A., Zavala, R., Brown, L.S., Bostrom, A., Ziedonis, D, Chan M. The New York Policy on Smoking in Addiction Treatment: Findings After 1 Year. American Journal of Public Health. 2012. 102(5):e17-e25.

 86.  Smelson, D., Kalman, D., Losonczy, M.F., Kline, A., Sambamoorthi, U., Hill, L.S., Castles-Fonseca, K., Ziedonis, D. A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community Mental Health J. 2012. 48(2), 127-132. doi: 10.1007/s10597-010-9346-9.

 87.  Kim, S.S., Chen, W., Kolodziej, M., Wang, X., Wang, V.J., Ziedonis, D. A Systematic Review of Smoking Cessation Intervention Studies in China.  Nicotine & Tobacco Research. 2012, 14(8):891-899.  doi: 10.1093/ntr/ntr289.

 88.  Boyer, E.W., Fletcher, R., Fay, R.J., Smelson, D., Ziedonis, D., Picard, R.W.   Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project.  Journal of Medical Toxicology. 2012. 8(1):5-9.

 89.  Ziedonis, D., Wang, X., Li, T., Kim, S. S., Tonelli, M., Li, S., & Kalman, D. Addressing tobacco through organizational change in West China Hospital’s Mental Health Center: The intervention and lessons learned in an implementation study. Journal of Dual Diagnosis. 2012. 8(2): 148-57.  DOI:10.1080/15504263.2012.672116

 90.  Ziedonis, D. & Kolodziej, M. E. Innovative Interventions for Treating Tobacco Addiction amongst Persons with Co-occurring Mental Illness and Addiction:  New Approaches to Improve Outcomes. Journal of Dual Diagnosis. 8(2), 85-88, 2012 DOI 10.1080/15504263.2012.672159

 91.  Kim, S. S., Fang, H., DiFranza, J., Ziedonis, D., & Ma, G. Gender differences in the Fagerström Test for Nicotine Dependence in Korean Americans. Journal of Smoking Cessation. 2012. 7(1), 1-6.  DOI: 10.1017/jsc.2012.5

 92.  Kim, S.S., Kim, S.H., Ziedonis, D.  Tobacco dependence treatment for Korean Americans: preliminary findings.  J Immigrant & Minority Health.  2012.  14(3), 395-404.

 93.  Smelson, D., Yu, L., Buyske, S., Gonzalez, G., Tischfield, J., Deutsch, C. K., & Ziedonis, D. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence. American J Addiction. 2012. 21(5): 411-415.

 94.  Byatt, N., Biebel, K., Debourdes-Jackson, G., Lundquist, R., Moore Simas, T., Weinreb, L., Ziedonis, D.  Community Mental Health Provider Reluctance to Provide Pharmacotherapy May Be a Barrier to Addressing Perinatal Depression: A Preliminary Study. Psychiatric Quarterly. 2013.  84(2), 169-174.

 95.  Smelson, D., Chen, K.W., Ziedonis, D., Andes, K., Lennox, A., Callahan, L., Rodrigues, S., Eisenberg, D.:  A pilot study of Qigong for reducing cocaine craving early in recovery.  J Alternative Complement Medicine. 2013. 19(2): 97-101.

 96.  Abar, B. Baumann, B.M., Rosenbaum, C., Boyer, E., Ziedonis, D., Boudreaux, E.D. Profiles of importance, readiness, and confidence in quitting tobacco use.  Journal of Substance Use, 2013. 18(2):75-81. 

 97.  Song, X., Fan, X., Song, X., Zhang, J., Zhang, W., Li, X., Gao, J., Harrington, A., Ziedonis, D., & Lv, L. Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight. Schizophrenia Research 2013 150(1): 269-73.

 98.  Kim, S., Seongho, K., McKay, C., Ziedonis, D.M.  Comparison of characteristics among Korean American male smokers between survey and cessation studies. Open Journal of Preventive Medicine. 2013. 3(3): 293-300.

 99.  Byatt, N., Biebel, K., Friedman, L., Debordes-Jackson, G., Pbert, L., Ziedonis, D.  Patient’s Views on Depression Care in Obstetric Settings:  How Do They Compare to the Views of Perinatal Health Care Professionals? General Hospital Psychiatry.  2013; 35(6):598. 

 100.         Huang W1, DiFranza JR, Kennedy DN, Zhang N, Ziedonis D, Ursprung S, King JA. Progressive levels of physical dependence to tobacco coincide with changes in the anterior cingulum bundle microstructure.   PLoS One. 2013 8(7):e67837-44.  doi: 10.1371/journal.pone.0067837

 101.         Kim, S.S., Chung, S., Park, J.I., Jung, A.J., Kalman, D., Ziedonis, D.M.  Smoking among individuals with schizophrenia in Korea: Gender differences. Archives of Psychiatric Nursing. 2013. 27(5):241-5.  doi: 10.1016/j.apnu.2013.06.002

 102.         Ding ,M., Song, X., Zhao, J., Gao, J., Li, X., Yang, G., Wang, X., Harrington, A., Ziedonis, D., Fan, X., Lv, L.  Activation of Th17 cells in drug naïve, first episode schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 2014; 51: 78-82. PMID: 24447943.

 103.         Kim, S., Lee, H., Kiang, P., Kalman, D., Ziedonis, D.M. Factors associated with alcohol problems among Asian American college students: Gender, ethnicity, smoking and depressed mood. Journal of  Substance Use. 2014. (1-2): 12-17. 

 104.         Byatt, N., Biebel, K., Friedman, L., Debordes-Jackson, G., Ziedonis, D.M.  Women’s perspectives on postpartum depression screening in pediatric settings:  a preliminary study.  Archives of Women’s Mental Health. 2013. 16(5):429-32.

 105.        Song, X., Fan, X., Li, X., Zhang,W., Gao, J., Zhao, J., Harrington, A., Ziedonis, D., Lv, L. Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia. Psychopharmacology (Berl). 2014. 231(2):319-25.

 106.        Anderson, M.L., Ziedonis, D.M., & Najavits, L.M.  Posttraumatic stress disorder and substance use disorder comorbidity among individuals with physical disabilities: Findings from the National Comorbidity Survey Replication. Journal of Traumatic Stress. 2014; 27(2), 182-191.

 107.         Kim, S.S., Fang, H., McKee, S.A., & Ziedonis, D.M.  Prospective Evaluation of Factors Predicting Nicotine Withdrawal symptoms Among Korean Americans. Journal of Smoking Cessation. 2014; 11(3), 154-162.

 108.         Song, X., Fan, X., Zhang, J., Zheng, H., Li, X., Pang, L., Chen, X., Zhang, W., Harrington, A., Ziedonis, D., Lv, L. Prolactin serum levels correlate with inflammatory status in drug-naïve first-episode schizophrenia. World J Biological Psychiatry, 2014 15(7):546-52. doi: 10.3109/15622975.2014.922699. PMID:24959913

 109.         Huang, W., King, J., Ursprung, S., Zheng, S., Zhang, N., Kennedy, D., Ziedonis, D., & DiFranza, J. The Development and Expression of Physical Nicotine Dependence Corresponds to Structural and Functional Alterations in the Anterior Cingulate-Precuneus Pathway. Brain and Behavior, 2014; 4: 408–417. doi: 10.1002/brb3.227.

 110.         Song, X., Quan, M., Lv, L., Li X., Pang, L., Kennedy, D., Hodge, S., Harrington, A., Ziedonis, D., Fan, X. Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF. Journal Psychiatric Research, 2015. 60, 22-8. 

 111.         Byatt, N., Levin, L.L., Ziedonis, D., Moore Simas, T.A., Allison, J. Enhancing participation in depression care in outpatient perinatal care settings: A systematic review. Obstetrics and Gynecology.  2015; 126(5):1048-58.

 112.         Kelly, M., Sido, H., Forsyth, J., Ziedonis, D., Kalman, D., Cooney, J. Acceptance and commitment therapy smoking cessation treatment for veterans with posttraumatic stress disorder: A pilot study. J Dual Diagnosis. 2014. 11(1), 50-55.

 113.         Kim, S.S., Kim, S.H., Fang, H., Kwon, S., Shelley, D., & Ziedonis, D.M.  A culturally adapted smoking cessation intervention for Korean Americans: A mediating effect of perceived family norm toward quitting. Journal of Immigrant and Minority Health. 2015. 17(4): 1120-9.

 114.        Li, M., Wei, D., He, Z., Wang, Q., Huang, C., Jiang, L., Ziedonis, D.M., King, J.A., Ma, X., Zhang, N., Li, T.   A splitting brain: Imbalanced neural networks in schizophrenia. Psychiatry Research Neuroimaging. 2015. 232 (2): 145-153.

 115.         Chung, S., Kim, S.S., Kini, N., Fang, H.J., Kalman, D., & Ziedonis, D.M. Smoking Topography in Korean American and White Men: Preliminary Findings. J Immigrant Minority Health.   2015. 17: 860 - 66.

 116.        Du, J., Quan, M., Zhuang, W., Zhong, N., Juang, H., Kennedy, D., Harrington, A., Ziedonis, D., Fan, X., Zhao, M.  Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behavioural Brain Research, 2015. 289: 78-83.

    117.        Byron, G., Ziedonis, D., McGrath, C., Frazier, J., deTorrijos, F. & Fulwiler, C. Implementation of Mindfulness Training for Mental Health Staff: Organizational Context and Stakeholder Perspectives. Mindfulness. 2015: 6(4):861-872.  

  118.        Wang, X., Peng, Z., Ziedonis, D.M., Wang, C., Yu, B., Li, T. Evaluation of tobacco use on Chinese population through ATTOC model: a cross-sectional survey on hospitalized psychiatric patients. In J Clin Exp Med. 2015; 8(4), 6008-6015.

 119.        Gonzalez, G., DiGirolamo, G., Romero-Gonzalez, M., Smelson, D., Ziedonis, D. Kolodziej, M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015 156: 243-253.

  120.        Anderson, M.L., Wolf Craig, K.S., Hall, W.C., Ziedonis, D.M. A Pilot Study of Deaf Trauma Survivors Experiences, Early Traumas Unique to Being Deaf in a Hearing World. Journal of Child and Adolescent Trauma. 2016 9 (4): 353 – 358.

 121.        Anderson, M.L., Sortwell, A., Wolf Craig, K.S. & Ziedonis, D.M. Symptom Patterns of Posttraumatic Stress Disorder among Deaf Trauma Survivors. JADARA. 2016; 50(1): 1-21. Retrieved from http://repository.wcsu.edu/jadara/vol50/iss1/3

 122.        Byatt, N., Pbert, L., Hosein, S., Swartz, H., Weinreb, L., Allison, J. Ziedonis, D. Program In Support of Moms (PRISM); Development and Beta Testing.  Psychiatric Services. 2016; 67(8), 824-826; doi: 10.1176/appi.ps.201600049.

 123.        Murphy, K.M. & Ziedonis, D.M. (2016). Group Guided Imagery and Music for adults in addiction treatment: A pilot randomized control trial feasibility study. Journal of the Association for Music and Imagery, 2016.  15, 43-65.

 124.        Gordon, C., Gidugu, V., Rogers, E.S., DeRonk, J., Ziedonis, D. Adapting Open Dialogue for early onset psychosis into the U.S. healthcare environment: A feasibility study. Psychiatric Services. 2016.  67(11):1166-1168.  doi: 10.1176/appi.ps.201600271.

 125.        Kim, S., Sitthisongkram, S., Bernstein, K., Fang, H., Choi, W., Ziedonis, D. A randomized controlled trial of a videoconferencing smoking cessation intervention for Korean American women: preliminary findings. International Journal of Women’s Health. 2016 (8), 453-462. DOI https://doi.org/10.2147/IJWH.S109819

 126.        Chen, L., Baker, T., Brownson, R., Carney, R., Jorenby, D., Hartz, S., Smock, N., Johnson, M., Ziedonis, D., Bierut, L. Smoking cessation and electronic cigarettes in community mental health centers: Patient and provider perspectives. Community Mental Health Journal.  2016 Nov 30. [Epub ahead of print] DOI: 10.1007/s10597-016-0065-8  PMID:27900650

  127.        Anderson, M. L., Wolf Craig, K. S., & Ziedonis, D. M.  Deaf people’s help-seeking following trauma: Experiences with and recommendations for the Massachusetts behavioral healthcare system. Psychological Trauma: Theory, Research, Practice, and Policy. 2017. 9(2):239-248.

 128.        Brunette MF, Ferron JC, Robinson D, Coletti D, Geiger P, Devitt T, Klodnick V, Gottlieb J, Xie H, Greene MA, Ziedonis D, Drake RE, McHugo GJ. Brief Web-Based Interventions for Young Adult Smokers With Severe Mental Illnesses: A Randomized, Controlled Pilot Study.  Nicotine & Tobacco Research. 2017 Oct 14. doi: 10.1093/ntr/ntx190. [Epub ahead of print]

 129.        Byatt N, Moore Simas TA, Biebel K, Sankaran P, Pbert L, Weinreb L, Ziedonis D, Allison J. PRogram In Support of Moms (PRISM): a pilot group randomized controlled trial of two approaches to improving depression among perinatal women. J Psychosomatics Obstetric Gynaecology. 2017 Oct 10:1-10. doi: 10.1080/0167482X.2017.1383380. [Epub ahead of print]

 130.        Kim SS, Fang H, Bernstein K, Zhang Z, DiFranza J, Ziedonis D, Allison J. Acculturation, Depression, and Smoking Cessation: a trajectory pattern recognition approach. Tobacco Induced Disorders. 2017 Jul 24;15:33. doi: 10.1186/s12971-017-0135-x.

 131.        Anderson, M. L., Wolf Craig, K. S., & Ziedonis, D. M. Barriers and facilitators to deaf trauma survivors’ help-seeking behavior: Lessons for behavioral clinical trials research. Journal of Deaf Studies and Deaf Education.  2017. 1:118-130.   

 132.        Ivanovs R, Kivite A, Ziedonis D, Mintale I, Vrublevska J, Rancans E. Association of Depression and Anxiety With the 10-Year Risk of Cardiovascular Mortality in a Primary Care Population of Latvia Using the SCORE System.  Front Psychiatry. 2018 Jun 26;9:276. doi: 10.3389/fpsyt.2018.00276.

 133.        Thornton JD, Dwibedi N, Scott V, Ponte CD, Ziedonis D, Sambamoorthi N, Sambamoorthi U.   Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States.  Am Health Drug Benefits. 2018 Feb;11(1):12-21.

 134.        Wu C, Chiang M, Harrington A, Kim S, Ziedonis D, Fan X. Racial disparity in mental disorder diagnosis and treatment between non-hispanic White and Asian American patients in a general hospital.  Asian J Psychiatr. 2018 Apr;34:78-83. doi: 10.1016/j.ajp.2018.04.019. Epub 2018 Apr 9.

 135.        Ivanovs R, Kivite A, Ziedonis D, Mintale I, Vrublevska J, Rancans E.  Association of depression and anxiety with cardiovascular co-morbidity in a primary care population in Latvia: a cross-sectional study. BMC Public Health. 2018 Mar 6;18(1):328. doi: 10.1186/s12889-018-5238-7.

 136.        Kim, S. S., Bernstein, K., Olivia, H., Fang, H., McKee, S., & Ziedonis, D. Remote biochemical verification of smoking abstinence via a mobile-phone video call with Korean American women. Journal of Mobile Technology in Medicine, 2018. 7(1), 1-7.

 137.        Vilardaga R, Rizo J, Ries RK, Kientz JA, Ziedonis DM, Hernandez K, McClernon FJ.Formative, multimethod case studies of learn to quit, an acceptance and commitment therapy smoking cessation app designed for people with serious mental illness.  Transl Behav Med. 2018 Nov 16. doi: 10.1093/tbm/iby097. PMID: 30445507

 138.        Flitter, A., Lubitz, S., Ziedonis, D., Stevens, N., Leone, F., Mandell, D., Kimberly, J., Lopez, O., Beidas, R., & Schnoll, R. A cluster-randomized clinical trial testing the effectiveness of the addressing tobacco through organizational change (ATTOC) model for improving the treatment of tobacco use in community mental healthcare: preliminary study feasibility and baseline findings. Nicotine and Tobacco Research. 2019 Apr 17;21(5):559-567. doi: 10.1093/ntr/nty239. PMID: 30388273

 139.        Wachholtz A, Gonzalez G, Ziedonis D. Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence. Am J Drug Alcohol Abuse. 2019;45(5):495-505. doi: 10.1080/00952990.2019.1620260.

 140.        Lubitz SF, Flitter A, Wileyto EP, Ziedonis D, Stevens N, Leone F, Mandell D, Kimberly J, Beidas R, Schnoll RA.  History and Correlates of Smoking Cessation Behaviors among Smokers with Serious Mental Illness.  Nicotine Tob Res. 2019 Dec 9. pii: ntz229. doi: 10.1093/ntr/ntz229.

 141.        Li ML, Johnson S, Ziedonis D.   Leading Change: Motivational Conversation Can Fuel Effective Action.    Journal of Innovation and Healthcare Management. 2019. Vol. 2: 1–5.    DOI: 10.20396/jihm.v2i0.11800. 

 142.        Rancans E, Vrublevska J, Kivite-Urtane A, Ivanovs R, Ziedonis D.  Prevalence of major depression and associated correlates in Latvian primary care population: results from the National Research Program BIOMEDICINE 2014-2017. Nordic Journal of Psychiatry. 2020. 74 (1): 60-68. doi: 10.1080/08039488.2019.1668961

 143.        Taube M, Ziedonis D, Ozerska D.  Adapting Open Dialogue for Early-Onset Psychosis In Latvia: Barriers and Facilitators.  Proceedings of the Latvian Academy of Sciences.  2020. Vol 74. No. 6. (729), pp. 410–414, 2020.  DOI: 10.2478/prolas-2020-0060

 144.        Rancans E, Renemane L, Kivite-Urtane A, Ziedonis D. Prevalence and associated factors of mental disorders in the nationwide primary care population in Latvia: a cross-sectional study.  Annals of General Psychiatry. 2020. Vol 19:25 (pages 1-10). doi: 10.1186/s12991-020-00276-5.

 145.        Jeste DV, Di Somma S, Lee EE, Nguyen TT, Scalcione M, Biaggi A, Daly R, Liu J, Tu X, Ziedonis D, Glorioso D, Antonini P, Brenner D. Study of loneliness and wisdom in 482 middle-aged and oldest-old adults: a comparison between people in Cilento, Italy and San Diego, USA. Aging Ment Health. 2021 Nov;25(11):2149-2159. doi: 10.1080/13607863.2020.1821170. Epub 2020 Oct 1. PMID: 33000647; PMCID: PMC8012404.

 146.        Chumachenko SY, Cali RJ, Rosal MC, Allison JJ, Person SJ, Ziedonis D, Nephew BC, Moore CM, Zhang N, King JA, Fulwiler C. Keeping weight off: Mindfulness-Based Stress Reduction alters amygdala functional connectivity during weight loss maintenance in a randomized control trial.  PLoS One. 2021 Jan 11;16(1):e0244847. (pages 1-18). doi: 10.1371/journal.pone.0244847. eCollection 2021. PMID: 33428638 

 147.        Servis M, Fishman SM, Wallace MS, Henry SG, Ziedonis D, Ciccarone D, Knight KR, Shoptaw S, Dowling P, Suchard JR, Shah S, Singh N, Cedarquist LC, Alem N, Copenhaver DJ, Westervelt M, Willis BC.Responding to the Opioid Epidemic: Educational Competencies for Pain and Substance Use Disorder from the Medical Schools of the University of California.  Pain Med. 2021 Feb 4;22(1):60-66. doi: 10.1093/pm/pnaa399.  PMID: 33316051 

 148.        Siegel SD, Laurenceau JP, Hill N, Bauer AM, Flitter A, Ziedonis D, Stevens N, Hosie Quinn M, Leone F, Beidas R, Kimberly J, Schnoll RA. Assessing barriers to providing tobacco use disorder treatment in community mental health settings with a revised version of the Smoking Knowledge, Attitudes, and Practices (S-KAP) instrument.   Addict Behav. 2021 Mar;114:106735. (pages 1-15).   doi: 10.1016/j.addbeh.2020.106735. Epub 2020 Nov 19. PMID: 33248743 

 149.        Varisco TJ, Abughosh S, Chen H, Cho SK, Fleming ML, Ziedonis D, Thornton D. Switching pharmacies leads to gaps in medication possession in individuals treated with buprenorphine. J Am Pharm Assoc (2003). 2021 Sep-Oct;61(5):589-595. doi: 10.1016/j.japh.2021.04.014. Epub 2021 Apr 24. PMID: 34016547.

 150.        Masters GA, Brenckle L, Sankaran P, Moore Simas TA, Person SD, Allison J, Ziedonis D, Ko J, Robbins C, Byatt N. Development of the Practice Readiness to Evaluate and address Perinatal Depression (PREPD) assessment. Psychiatry Res. 2021 Aug;302:114032. doi: 10.1016/j.psychres.2021.114032. Epub 2021 May 29. PMID: 34111739; PMCID: PMC8277728.

 151.        Nobles AL, Johnson DC, Leas EC, Goodman-Meza D, Zúñiga ML, Ziedonis D, Strathdee SA, Ayers JW. Characterizing Self-Reports of Self-Identified Patient Experiences with Methadone Maintenance Treatment on an Online Community during COVID-19. Subst Use Misuse. 2021 Sep 5:1-7. doi: 10.1080/10826084.2021.1972317. Epub ahead of print. PMID: 34486471.

 152.        Bhatt SR, Armstrong M, Parker T, Maviglia M, Kass R, Leeman L, Romo P, Ziedonis D. Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico. Frontiers in Pharmacology. 2022 Jun 27; 13:905753. (pages 1-12). doi: 10.3389/fphar.2022.905753. PMID: 35833023; PMCID: PMC9273054.

 153.        Lotmore M, Ziedonis D, Alvarez Monjaras M, Hopfenbeck M, Razzaque R, Wilson E, Pilling S. Development and refinement of the open dialog adherence protocol in complex mental health care. Frontiers in Psychology. 2023 Jan 6;13:1041375. (pages 1-13).  doi: 10.3389/fpsyg.2022.1041375. PMID: 36687823; PMCID: PMC9853976.

 154.        Schnoll RA, Leone FT, Quinn MH, Stevens N, Flitter A, Wileyto P, Kimberly J, Beidas RS, Hatzell J, Siegel SD, Crawford G, Hill N, Deatley T, Ziedonis D. A randomized clinical trial testing two implementation strategies to promote the treatment of tobacco dependence in community mental healthcare. Drug Alcohol Depend. 2023 Jun 1;247:109873. (pages 1-23).  doi: 10.1016/j.drugalcdep.2023.109873. Epub 2023 Apr 12. PMID: 37084508; PMCID: PMC10198962.

 155.        Tai-Seale M, Baxter S, Millen M, Cheung M, Zisook S, Çelebi J, Polston G, Sun B, Gross E, Helsten T, Rosen R, Clay B, Sinsky C, Ziedonis DM, Longhurst CA, Savides TJ. Association of physician burnout with perceived EHR work stress and potentially actionable factors. J Am Med Inform Assoc. 2023 Sep 25;30(10):1665-1672. doi: 10.1093/jamia/ocad136. PMID: 37475168; PMCID: PMC10531111.

 156.        Cotes RO, Palanci JM, Broussard B, Johnson S, Grullón MA, Norquist GS, Mehta CC, Wood K, Cubellis L, Gholami M, Ziedonis D. Feasibility of an Open Dialogue-Inspired Approach for Young Adults with Psychosis in a Public Hospital System. Community Ment Health J. 2023 Oct;59(7):1428-1435. doi: 10.1007/s10597-023-01120-2. Epub 2023 Mar 20. PMID: 36939990.

 157.        Foster CD, Quinn MH, Koita F, Leone FT, Stevens N, Siegel SD, Wileyto EP, Ziedonis D, Schnoll RA. Predictors of improved clinician screening, assessment, and treatment for tobacco use for clients in community mental healthcare following training. Drug Alcohol Depend Rep. 2023 Nov 23;9:100208. (pages 1-5). doi: 10.1016/j.dadr.2023.100208. PMID: 38094574; PMCID: PMC10715997.

 158.        O'Hea EL, Edwards-Hampton SA, Beall Brown DL, Sonneville KR, Ziedonis DM, Gearhardt AN. The Food Addiction Clinical Treatment (FACT) Manual: A Harm Reduction Treatment Approach. Behavioral Sciences (Basel). 2024 Jul 1;14(7):557. (pages 1-15).  doi: 10.3390/bs14070557. PMID: 39062380; PMCID: PMC11273413.  

 Major Reviews: NIH, IOM, and Royal College of Physicians

 1.     Ziedonis, D., Hitsman, B., Beckham, J.C., Zvolensky, M., Adler, L.E., Audrain-McGovern, J., Breslau, N., Brown, R.A., George, T.P., Williams, J., Calhoun, P.S., Riley, W.T.  Tobacco use and cessation in psychiatric disorders:  National Institute of Mental Health Report.  Nicotine & Tobacco Research, 2008. 10(12):1691-715.

 2.     Committee on Smoking Cessation in Military Veteran Populations.  Combating Tobacco Use in Military and Veteran Populations.  Institute of Medicine of the National Academies:  Washington, DC.  (Committee members:  Bondurant S, Benowitz N, Curry, S, Gritz E, Jacobson P, Kizer K, Klesges, R, Koh H, Mariner W, Martinez-Donate A, Meara E, Peterson A, Stillman F, Wyatt E, Ziedonis D). 2009.

 3.     Royal College of Physicians, Royal College of Psychiatrists. Smoking and mental health. London: RCP.  Royal College of Psychiatrists.  Council Report CR178.  (Contributors: Howard L, Huang Y, Jarvis M, Kalman D, Leonardi-Bee J, MacAskill S, Mei-See Man S, McNally L, McNeill SA, Munafò M, Newlove-Delgado T, Parker C, Parrott S, Piné-Abata H, Ratschen E, Rowe M, Szatkowski L, Shorter G, Stewart R, Whittington C, Williams J, Wu Q, & Ziedonis DM).  1-201, 2013.

 Reviews:  Clinical Practice Guidelines in Journal Supplements and Publications

 1.     Hughes, J.R., Fiester, S., Goldstein, M., Resnick, M., Rock, N., and Ziedonis, D.M. American Psychiatric Association ‘s Practice Guidelines for the Treatment of Patients With Nicotine Dependence. American Journal of Psychiatry 153 (10, entire supplement), 1 – 31. 1996.

 2.     Work Group on Substance Use Disorders: Kleber, H.D., Weiss, R.D., Anton, R.F., Rounsaville, B.J., George, T.P., Strain, E.C., Greenfield, S.F., Ziedonis, D.M., Kosten, T.R., Hennessy, G., O’Brien, C.P., Connery, H.S. American Psychiatric Association Steering Committee on Practice Guidelines; McIntyre, J.S., Charles, S.C., Anzia, D.J., Nininger, J.E., Cook, I.A., Summergrad, P., Finnerty, M.T., Woods, S.M., Johnson, B.R., Yager, J., Pyles, R., Lurie, L., Cross, C.D., Walker, R.D., Peele, R., Barnovitz, M.A., Gray, S.H., Shemo, J.P., Saxena, S., Tonnu, T., Kunkle, R., Albert, A.B., Fochtmann, L.J., Hart, C., Regier, D.. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. American Journal of Psychiatry.  2006. 163(8, Supplement):5-82.

 3.     Kleber, H.D., Weiss, R.D., Anton Jr., R.F., George, T.P., Greenfield, S.F., Kosten, T.R., O'Brien, C.P., Rounsaville, B.J., Strain, E.C., Ziedonis, D.M., Hennessy, G., Connery, H.S., McIntyre, J.S., Charles, S.C., Anzia, D.J., Cook, I.A., Finnerty, M.T., Johnson, B.R., Nininger, J.E., Summergrad, P., Woods, S.M., Yager, J., Pyles, R., Cross, C.D., Peele, R., Shemo, J.P., Lurie, L., Walker, R.D., Barnovitz, M.A., Gray, S.H., Saxena, S., Tonnu, T., Kunkle, R., Albert, A.B., Fochtmann, L.J., Hart, C., Regier, D. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. The American Journal of Psychiatry.  2007: 164 (4 Suppl), pp. 5-123

 4.     Center for Substance Abuse Treatment. Substance Abuse Treatment for Persons With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. DHHS Publication No. (SMA) 05-3992. Rockville, MD: Substance Abuse and Mental Health Services Administration, (Authors / Panelists: Sacks, S., Ries, R., McNelis, D.M., Mee-Lee, D., Sorenson, J.L., Ziedonis, D.M., Zweben, J.E., Blackmon, B., Cantu, S., Chichester, C.S., Clark, C., Cline, C.A., Daw, R., Ekleberry, S.C., Fujita, B.N., Gallant, L.E., Harle, M., Kirby, M.W., Minkoff, K., Najavits, L.M., and Soto, T.A.). 2005.

 5.     SAMHSA. Pharmacologic Guidelines for Treating Individuals with Post-Traumatic Stress Disorder and Co-Occurring Opioid Use Disorder (Ziedonis, D – Member – Pharmacotherapy Expert Consensus Panel) HHS Pub. No. SMA-12-4688. 2012.

 6.     SAMHSA. General Principles for the Use of Pharmacological Agents to Treat Individuals with Co-Occurring Mental and Substance Use Disorders (Ziedonis, D – Member – Pharmacotherapy Expert Consensus Panel) HHS Pub. No. SMA-12-4689. 2012.

  Review Articles

 1.     Cadieux, R.J. and Ziedonis, D.M. Dementia: Differential Diagnosis and Evaluation. Family Practice Recertification 7(12):55-90, 1985.

 2.     Ziedonis, D.M. and Kosten, T.R. Behavioral Pathology (Substance use disorder classification and subtyping).  Annual Review of Addictions Research and Treatment 2:109-123, 1992.

 3.     Ziedonis, D.M. Diagnosing and Treating Comorbid Psychosis and Substance Abuse.  Current Approaches to Psychoses 2:6-12, 1993.

 4.     Ziedonis, D.M., Rao, S., and Preisig, M. Comorbidity Blues: Diagnosing and Treating Depression among Substance Abusers.  Employee Assistance 6:6-34, 1994.

 5.     Ziedonis, D.M. and Fischer, W.  Assessment and Treatment of Comorbid Substance Abuse in Individuals with Schizophrenia. Psychiatric Annals 24:477-483, 1994.

 6.     Rao, S., Ziedonis, D.M., and Kosten, T.R.  The Pharmacotherapy for Cocaine Dependence.  Psychiatric Annals 25:363-368, 1995.

 7.     Ziedonis, D.M. and Fisher, W.  Motivation Based Assessment and Treatment of Substance Abuse in Patients with Schizophrenia.  New Directions in Psychiatry 16:1-8, 1996.

 8.     Kosten, T. and Ziedonis, D.M.  Substance Abuse and Schizophrenia.  Schizophrenia Bulletin 23(2):181-186, 1997.

 9.     Ziedonis, D.M. and Brady, K.  Dual Diagnosis in Primary Care.  Medical Clinics of North America 81(4):1017-1036, 1997.

 10.  Ziedonis, D., Williams, J. Corrigan, P., and Smelson, D.  Management of Substance Abuse in Schizophrenia. Psychiatric Annals.   2000. 30(1):67–75, 2000.

 11.  McCrady, B. and Ziedonis, D. American Psychiatric Association Guideline for Substance Use Disorders.  Journal of Behavioral Therapy.   32:309-336, 2001.

 12.  Krejci, J. and Ziedonis, D.M.  Medications in the treatment of addiction: workplace issues. Occupational Medicine. 17(1):91-104, 2002. 

 13.  Boyarsky, B.K., Dilts, S., Frances, R.J., Frosch, W.A., Galanter, M., Levin, F., Lewis, C., Loomis, E., Menninger, J.A., Nace, E.P., Suchinsky, R., Sullivan, M., Tamerin, J., Westermeyer, J., Wolkoff, D., Ziedonis, D. Responsibility and choice in addiction (2002) Psychiatric Services.  2002.  53 (6): 707-713.

 14.  Ziedonis, D.M. and Williams, J.  Management of Smoking in People with Psychiatric Disorders.  Current Opinion in Psychiatry. 16 (3):305-315, 2003.

 15.  Ziedonis, D.M. and Williams, J.  Addressing Tobacco Use in Mental Health and Addiction Settings. Psychiatric Annals. 33(7):425-426, 2003.

 16.  Stuyt, E.B., Order-Connors, B., and Ziedonis, D.M.  Addressing Tobacco through Program and System Change in Mental Health and Addiction Settings.  Psychiatric Annals.  33(7):446-456, 2003.

 17.  Ziedonis, D.M. Williams, J.M. Smelson, D.A. Serious Mental Illness and Tobacco Addiction: A Model Program to Address this Common but Neglected Issue.  American Journal of the Medical Sciences 326(4):223-30, 2003

 18.  Foulds, J., Burke, M., Steinberg, M., Williams, J.M. and Ziedonis, D.M..  Advances in Pharmacotherapy for Tobacco Dependence.  Expert Opinion in Emerging Drugs.  9(1):39-51, 2004.

 19.  Williams, J.M. and Ziedonis, D.M. Addressing Tobacco among Individuals with a Mental Illness or an Addiction. Addictive Behaviors. 29(6):1067-1083, 2004.

 20.  Ziedonis, D.M., Smelson, D.A., Rosenthal, R.N., Batki, S.L., Green, A.I., Henry, R.J., Montoya, I., Parks, J., Weiss, R.D.  Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatric Practice 11(5):315-39, 2005.

 21.  Yanos, P.T., Ziedonis, D.M. The patient-oriented clinician-researcher: advantages and challenges of being a double agent. Psychiatric Services 57(2):249-53, 2006.

 22.  Ziedonis, D.M., Williams, J.M., Steinberg, M., Foulds, J. Addressing tobacco addiction in office-based management of psychiatric disorders: practical considerations. Primary Psychiatry 13(2):51-63, 2006.

23.  Ziedonis, D.M., Haberstroh, S., Hanos Zimmermann, M., Miceli, M., Foulds, J. Adolescent tobacco use and dependence: assessment and treatment strategies. Adolescent Medicine Clinics 17(2):381-410, 2006.

 24.  Ziedonis, D.M., Guydish, J., Williams, J., Steinberg, M., Foulds, J. Barriers and Solutions to Addressing Tobacco Dependence in Addiction Treatment Programs. Alcohol and Tobacco, Alcohol Research and Health, 29(3), 228-235, 2006.

 25.  Kim, S.S., Ziedonis, D.M. and Chen, K.W.  Tobacco use and dependencies in Asian Americans: A review of the literature. Nicotine and Tobacco Research 9:169-184, 2007.

 26.  Ziedonis, D.M., Parks, J., Hanos Zimmermann, M., McCabe, P. Program and System Level Interventions to Address Tobacco Amongst Individuals with Schizophrenia.  Journal of Dual Diagnosis 3(3/4): 151-175, 2007.

 27.  Ziedonis, D.M., Montoya, I.D. Tobacco dependence amongst individuals with schizophrenia: A public health crisis and an opportunity for bidirectional translational research. Journal of Dual Diagnosis, 2007. 3 (3-4): 3-7.

 28.  Gardner, P.D, Tapper, A.R., King, J.A., Ziedonis, D.M.  The Neurobiology of Nicotine Addiction:  Clinical and Public Policy Implications.  Journal of Drug Issues. 39: 1045-1067, 2009.

 29.  Kalman ,D., Kim, S. DiGirolamo, G., Smelson, D., Ziedonis, D.  Addressing tobacco use disorder in smokers in early remission from alcohol dependence:  The case for integrating smoking cessation services in substance use disorder treatment programs.  Clinical Psychology Review 2010. 30 (1):12-24.

 30.  Boyer, E.W., Smelson, D., Fletcher, R., Ziedonis, D.M., Picard, R.W.   Wireless Technologies, ubiquitous Computing and Mobile Health:  Application to Drug Abuse Treatment and compliance with HIV Therapies.  Journal of Medical Toxicology. 2010 6(2): 212-6.

 31.  Wachholtz, A., Ziedonis, D., Gonzalez, G.  Comorbid Pain and Opioid Addiction:  Psychosocial and Pharmacological Treatments.  Substance Use & Misuse, 2011; 46(12):1536-52.

 32.  Wachholtz, A., Gonzalez, G., Boyer, E., Naqvi, Z., Rosenbaum, C., & Ziedonis, D. The intersection of chronic pain treatment and opioid analgesic misuse: A review of the causes, treatments, and policy strategies. Substance Abuse and Rehabilitation Review. 2011; 2: 145-162.

 33.  Byatt, N. Moore Simas, T. A. Lundquist, R. S., Johnson, J. V., & Ziedonis, D. M. Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. Journal of Psychosomatic Obstetrics & Gynecology. 2012. 33(4), 143–161

 34.  Pating, D.R., Miller, M.M., Goplerud, E., Martin, J., Ziedonis, D.M. New systems of care for substance use disorders: treatment, finance, and technology under health care reform. Psychiatric Clinics North America. 2012. 35(2), 327-356. doi: 10.1016/j.psc.2012.03.004

 35.  Mistler, L.A., Brunette, M.F., Ferron, J.C., & Ziedonis, D. Shared Decision Making and Tobacco Dependence Treatment for People with Severe Mental Illnesses. Journal of Dual Diagnosis. 2012. 8(2), 99-103.  DOI: 10.1080/15504263.2012.671093

 36.  Ziedonis, D., Das, S., Tonelli, M. Smoking and mental illness: Strategies to increase screening, assessment, and treatment. FOCUS. 2015: 13(3) 290-306.

 37.  Mitra S, Natarajan R, Ziedonis D, Fan X. Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia.  Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 1;78:1-11. doi: 10.1016/j.pnpbp.2017.05.005. Epub 2017 May 9.

  Letters:

 1.      Kosten, T.R., Schottenfeld, R., Ziedonis, D., Falcioni, J. Comparing Buprenorphine and Methadone Maintenance: Reply to Dr. Newman. Journal of Nervous and Mental Disease, 1994. 182 (4), 246. 

 Invited Articles:

 1.     Brewster, T., Farentinos, C., Ziedonis, D. Response: the neurobiological model in community treatment programs. Sci Pract Perspect. 2002. 1(1):21.

 2.     Ziedonis, D.M. and Williams, J.  When Psychosis and substance use coincide in the emergency service.  Psychiatric Issues in Emergency Care Settings. Summer Issue: 3–13, 2002.

 3.     Williams, J. and Ziedonis, D.M.  Emergency management of psychosis and substance abuse.  Psychiatric Issues in Emergency Care Settings. 2002: 2: 14–19.

 4.     Brewster, T., Farentinos C., Ziedonis, D.  Response:  implementing motivational stepped care.  Sci Pract Perspect. Jul 1(1):47-8, 2002.

 5.     Ziedonis, D.M. Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectrum 9(12):892-904, 2004.

 6.     Foulds, J., Steinberg, M.B., Williams, J.M., Ziedonis, D.M. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev 25(1):59-71, 2006.

 7.     Williams, J.M., Ziedonis, D.M. Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved. Behavioral Healthcare 26(5):27-31, 2006.

 8.     Ziedonis, D.M., Dual Diagnosis: The Evolving Conceptual Framework. Psychiatric Services, 58(3): 416, March 2007.

 9.     George, T. and Ziedonis, D.  Addressing tobacco dependence in psychiatric practice:  Promises and pitfalls.  Canadian Journal of Psychiatry, 2009. 54(6): p. 137-139.

 10.  McKay, C., Ziedonis, D., Seward, G., Williams, V., Bradley, K., Colburn, J., & Rocheleau, David. Addressing Tobacco Use in Adult Mental Health Service Programs. Psychiatry Information in Brief 2009. 6(2): 1.

 11.  Guydish, J. and Ziedonis, D.  Introduction to the Theme Issue on Smoking and Substance Abuse. Journal of Drug Issues.  2009. 9: 245-256. 

 12.  Ziedonis, D. and Baker, S. Addressing Tobacco through Organizational Change (ATTOC). Psychiatry Information in Brief. 2011. 8(5): 1.

 13.  Ziedonis, D. and Olson, M. Preparing the Open Dialogue Approach for Implementation in the United States. Psychiatry Information in Brief.  9(10):1, 2012.

 14.  Ziedonis, D. M., & Kolodziej, M. E. Introduction to the Special Issue on innovative interventions for treating tobacco addiction among persons with co-occurring mental illness and addiction: new approaches to improve outcomes. Journal of Dual Diagnosis. 2012. 8:85-88.

 15.  Ziedonis, D.M., Fulwiler, C, Tonelli, M:  Integrating Mindfulness Into Your Daily Routine.  Vital Signs, a publication of the Massachusetts Medical Society. 2014. 19(2): 6.

 16.  Grimes-Smith, B. and Ziedonis, D. Implementing Wellness into Mental Health and Addiction Recovery: The Addressing Wellness Through Organizational Change (AWTOC) Approach. Psychiatry Information in Brief 12(4), 1, 2015.

 17.  Das, S., Tonelli, M., Ziedonis, D.  Update on Smoking Cessation: E-Cigarettes, Emerging Tobacco Products Trends, and New Technology-Based Interventions. Current Psychiatry Rep. 2016. 18(5):51. doi: 10.1007/s11920-016-0681-6.

 18.  Tonelli, M.., Fulwiler, C., de Torrijos, F., Ziedonis, D. Mindfulness in psychiatry program and emerging initiatives at the University of Massachusetts & UMass Memorial Health Care. Worcester Medicine, 2016. 80(2), 14 - 15.

 19.  Ziedonis, D., Larkin, C. and Apassani, R. Dignity in mental health practice and research: Time to unite on innovation, outreach and education. Indian Journal of Medical Research. 2016. 144: 491-495.  DOI: 10.4103/0971-5916.200885. 

 20.  Ziedonis D, Das S, Larkin C. Tobacco use disorder and treatment: new challenges and opportunities.  Dialogues in Clinical Neuroscience. 2017 Sep;19(3):271-280.

 21.  Ziedonis D.  Looking for the healthy aging pathways to subjective well-being: the road to personal empowerment and enhanced self-care.  International Psychogeriatrics. 2019 Apr;31(4):451-453.

 22.  Ahn MS, Ziedonis D. Coaching Health Care Leaders and Teams in Psychiatry. Psychiatric Clinics of North America. 2019 Sep;42(3):401-412. doi: 10.1016/j.psc.2019.05.010.

 23.  Ziedonis D, Ahn MS. Professional Development for Clinical Faculty in Academia: Focus on Teaching, Research, and Leadership.  Psychiatric Clinics of North America. 2019 Sep;42(3):389-399. doi: 10.1016/j.psc.2019.05.009.

24.  Ziedonis D.  Communicating Science to Health Care Professionals: UNM’s Project ECHO.  Alliance of Academic Health Centers International: Leadership Perspectives.  2023 (2): 7-8.  

 Books / Monographs:

 1.     Coombs, R.H. and Ziedonis, D.M. (eds).  Handbook on Drug Abuse Prevention: A Comprehensive Strategy to Prevent the Abuse of Alcohol and Other Drugs. Allyn and Bacon.  Boston. 1995.

 2.     American Psychiatric Association.  Practice Guidelines for the Treatment of Patients With Nicotine Dependence.  American Psychiatric Press Inc. Washington DC, 1996. (Work Group on Nicotine Dependence co-authors: Hughes, J.R., Fiester, S., Goldstein, M., Resnick, M., Rock, N., and Ziedonis, D.M.), 1996.

 3.     Krauss, M.L., Segal, S.R., Frantz, A.H., and Ziedonis, D.M.  The Governor’s Blue Ribbon Task Force on Substance Abuse Report.  Hartford, CT.  1996.

 4.     Ziedonis, D.M. and Simsarian, J.  Department of Mental Health and Addiction Services Dual Diagnosis Task Force Report.  DMHAS: Hartford, CT.  1997.

 5.     Group for the Advancement of Psychiatry: Substance Abuse Work Group.  Addiction Treatment:  A Case Approach to Avoiding Pitfalls.  APPI Press:  Washington, DC, 1998.

 6.     Slade, J., Ziedonis, D.M., Lindberg, D., Order-Connors B, and Hoffman A.  New Jersey Guidelines for Tobacco Dependence Treatment.  DAS: Trenton, NJ.  2000.

 7.     Westermeyer, J., Weiss, R., and Ziedonis, D.M.   Integrated Treatment for Mood and Substance Use Disorders.  John Hopkins University Press, Baltimore, MD.  2003.

 8.     Ziedonis D. Foreword.  Rewriting Life Scripts: Transformational Recovery for Families of Addicts. by Desjardins L, Oelklaus N, and Watson I.   Life Scripts Press.  Ann Arbor, MI.   2010. pp. ix – xii

 9.     Ziedonis D.  Foreword. The Imprint Journey: A Path of Lasting Transformation Into Your Authentic Self.  by Desjardins L.  Life Scripts Press.  Ann Arbor, MI.  2012. pp. vii – x

 Chapters: 

 1.     Ziedonis, D.M. Family Assessment and Therapy. UCLA Handbook of Psychiatry, Year Book Medical Publishers Inc., Chicago, 538-551, 1990.

 2.     Ziedonis, D.M.  Comorbid Psychopathology and Cocaine Addiction. In Kosten TR and Kleber HD (eds).  Clinician's Guide to Cocaine Addiction: Theory, Research and Treatment.  Guilford Press, New York, NY, 337-360, 1992.

 3.     Sullivan, M. and Ziedonis, D.M.  Treatment for Substance Abuse. In Sullivan EJ (ed.) Nursing Care of Clients With Substance Abuse.  Mosby-Year Book, Inc., St. Louis, 71-101, 1995.

 4.     Ziedonis, D.M.  Substance Abuse Prevention Strategies for Psychiatric Patients.  In Coombs RH and Ziedonis DM (eds.) Handbook on Drug Abuse Prevention: A Comprehensive Strategy to Prevent the Abuse of Alcohol and Other Drugs. Allyn and Bacon, Boston 445-469. 1995.

5.     Ziedonis, D.M. and Fisher, W.  Motivation Based Assessment and Treatment of Substance Abuse in Patients with Schizophrenia.  In The Hatherleigh Guide to Treating Substance Abuse (Part II). Hatherleigh Press, New York, NY 269-287, 1996.

 6.     Ziedonis, D.M. and D’Avanzo, K.  Schizophrenia and Substance Abuse.  In Kranzler HR and Rounsaville BJ (eds.) Dual Diagnosis and Treatment: Substance Abuse and Comorbid Medical and Psychiatric Disorders. Marcel Deker: New York, N.Y.  427-465, 1998.

 7.     Ziedonis, D.M., Wyatt, S.A. and George, T.P. Current Issues in Nicotine Dependence and Treatment. In:  McCance-Katz, E. and Kosten, T.R. New Treatments for Chemical Addictions. American Psychiatric Press Inc: Washington, D.C. 1-34, 1998.

 8.     Wyatt, S. and Ziedonis, D.M. Psychological and Psychiatric Consequences of Amphetamine Use.  In Tarter, R.S., Ammerman, R.T., Ott, P.J. (eds.) Sourcebook on Substance Use and Abuse. Plenum Press, New York, NY: 1998.

 9.     Ziedonis, D.M., Farren, C.K., and George, T. Depression and Substance Abuse.  In Tohen M (ed.) Comorbidity in Affective Disorders, Marcel Dekker, New York, NY, 27-56, 1999.

 10.  Ziedonis, D.M. and Wyatt, S.A. Psychosis and the Addicted Patient. In Miller N (ed.) Principles of Addiction Medicine, 2nd Edition. New York, NY: American Society of Addiction Medicine, 1999.

 11.  O’Connor, P.G. and Ziedonis, D.M.  Linkages Between Substance Abuse, Primary Care, and Mental Health Services.  In Miller N (ed.) Principles of Addiction Medicine.  New York, NY: American Society of Addiction Medicine.  1999.

 12.  Ziedonis, D.M. and Nickou, C.  Substance Abuse in Patients with Schizophrenia.  In Hwang M. (ed.) Schizophrenia and Co-morbid Conditions: Diagnosis and Treatment.  Washington, DC: American Psychiatric Press Inc., 187-222, 2001. 

 13.  Ziedonis, D.M., Krejci, J., and Atdjian, S. Integrating Medications and Psychotherapy in the Treatment of Alcohol, Tobacco and Other Drug Addictions.  In Kay J (ed.) Integrated Treatment of Psychiatric Disorders (Volume 20). Washington DC: American Psychiatric Press Inc., 79-111, 2001.

 14.  Ziedonis, D.M. and Krejci, J.  Pharmacotherapy in the treatment of Substance Use Disorders:  One Tool in the Toolbox.  In Robert Coombs (ed.) Addiction Recovery Tools: A Practical Handbook.  Thousand Oaks, CA:  Sage Publications, 81-98, 2001.

 15.  Krejci, J. and Ziedonis, D.M. Medications in the treatment of addiction: Workplace issues. In J. Zweben and S. Lambert (eds.) Addiction in the Workplace, Occupational Medicine: State of the Art Reviews. Philadelphia: Hanley and Belfus, 2002.

 16.  Ziedonis, D.M., Steinberg, M.L., Smelson, D.A. and Wyatt, S. Co-occurring addictive and psychotic disorders.  In A.W. Graham, T.K. Schultz, M.F. Mayo-Smith, R.K. Ries and B.B. Wilford (eds.) Principles of Addiction Medicine, Third Edition.  Chevy Chase, MD:  American Society of Addiction Medicine, 1297-1320, 2003.

 17.  Ziedonis, D.M. and Krejci, J.  Dual Recovery Therapy: Blending Psychotherapies for Depression and Addiction. In Westermeyer, J., Weiss, R., and Ziedonis, D.M. (eds.) Integrated Treatment for Mood and Substance Use Disorders.  John Hopkins University Press, Baltimore, MD, 90–121, 2003.

 18.  Ziedonis, D.M. and Fiester, S.  Substance Abuse:  Nicotine Dependence (Chapter 59).  In Tasman A (ed.) Psychiatry (2nd Edition).  John Wiley and Sons, London, UK. 2003.

 19.  Ziedonis, D.M., Steinberg, M.L., D’Avanzo, K. and Smelson, D.A. Schizophrenia and substance abuse.  In Kranzler, H.R. and Rounsaville, B.J. (eds.) Dual diagnosis and treatment: Substance abuse and comorbid medical and psychiatric disorders 2nd Edition. Marcel Deker: New York, NY, 387-436, 2004.

 20.  Ziedonis, D.M., Williams, J., Steinberg, M.L., Smelson, D.A., Sussner, B., Foulds, J., Krejci, J., and Violette, N.  Addressing Tobacco Dependence Amongst Individuals with a Psychiatric Disorder: A Neglected Epidemic of Major Clinical and Public Health Concern.  In Isaacs SL (ed.) VA In the Vanguard: Building on Success in Smoking Cessation.  Department of Veterans Affairs. 141-170, 2005.

 21.  Ziedonis, D., Yanos, P.T., Silverstein, S.M.  Relapse Prevention for Schizophrenia.  Therapist’s Guide to Evidence-Based Relapse Prevention, Elsevier, 2007.

 22.  Foulds, J., DeInevo, C., Ziedonis, D.M., Steinberg, M.B.  Health Effects of Tobacco, Nicotine, and Exposure to Tobacco Smoke Pollution (Chapter 13).  In Brick, J. (ed.)  Handbook of the Medical Consequences of Alcohol and Drug Abuse (2nd Edition).  The Haworth Press, Taylor & Francis Group, New York and London, 423-460, 2008. 

 23.  Ziedonis, D.M., Day, E., O’Hea, E.L., Krejci, J., Berman, J.A., Smelson, D.A. Treatment of Co-Occurring Psychiatric and Substance Use Disorders. In Tyrer, P. and Silk, K. (eds.) Cambridge Handbook for Effective Treatments in Psychiatry, Cambridge University Press. 442-458, 2008.

 24.  Ziedonis, D.M., Berman J., Lehn, M.D., Coameco, S.  Support Groups and Twelve-Step Programs in the Treatment of the Chronic Pain Patient. In Smith and Passik (eds.) Pain and Chemical Dependency, Oxford University Press, USA; 2008.

 25.  Ziedonis, D.M., Steinberg, M., Smelson, D.A., and Wyatt, S.A.  Co-Occurring Addiction and Psychotic Disorders. In Ries, R., Fiellin, D., Miller, S., Saitz, R. (eds).  Principles of Addiction Medicine, 4th Edition.  New York, NY: American Society of Addiction Medicine, 1193-1209, 2009

 26.  Gonzalez, G., Miozzo, R. and Ziedonis, D.  Substance Use Disorders.    In    Rothschild AJ (ed), for the Evidence-Based Guide to Antipsychotic Medications, American Psychiatric Publishing, Inc., Washington, DC, 125-144, 2010.     

 27.  Kim, S.S., Kalman, D., Gonzalez, G., Ziedonis, D. Substance Use disorder among Immigrants in the United States. In Sher, L. and Vilens A. (eds.) Immigration and Mental Health: Stress, Psychiatric Disorders and Suicidal Behavior Among Immigrants and Refugees. New York: Nova Science Publishers, 243 – 65, 2010.

 28.  Ziedonis, Kalman, Johnson, Mistler. Nicotine Dependence Management. Chapter 36 in Lowinson and Ruiz’s Substance Abuse: A Comprehensive Textbook. 5th Edition. Editors: Pedro Ruiz, Eric C. Strain. Lippincott Williams and Wilkins. Philadelphia. 2011.

 29.  Ziedonis, D., Bizamcer, A.N., Steinberg M.L., Wyatt, S.A. Smelson, D.A. Vaiana, A.D.      Co-Occurring Addiction and Psychotic Disorders.  In Cavacuita, C.A. (ed). Principles of Addiction Medicine:  The Essentials, 4th Edition,  Chapter 86, 2011

 30.  Williams JM, Delnevo C, & Ziedonis DM.  The Unmet Needs of Smokers with Mental Illness or Addiction.  In After Tobacco: What Would Happen If Americans Stopped Smoking? Bearman, Neckerman and Wright (Eds).  Columbia University Press, 2011.

 31.  Ziedonis, D.M., Kalman, D., Kolodziej, M., Johnson, C.W., Kim. S.  Tobacco Addiction and Psychological Co-morbidities.  In Pagoto, Sherry (ed) Psychological Co-morbidities of Physical Illness:  A Behavioral Medicine Perspective. 207-232, 2011

 32.  Ziedonis, D.M., Fan, X., Bizamcer, A. N., Wyatt, S. A., Tonelli, M. E., Smelson, D.A.  Co-Occurring Addiction and Psychotic Disorders. In R. Ries et al. (eds), Principles of Addiction Medicine, Fifth Edition.  New York, NY: American Society of Addiction Medicine. 1346-1364, 2014.

 33.  Kalman, D., Hayes, R., Ziedonis, D:  Tobacco Use Disorder.  In M Galanter, et al. (eds), Textbook of Substance Abuse Treatment.  Arlington, VA:  American Psychiatric Publishing.  223-237, 2015.

 34.  Ziedonis, D.M., Fan, X., Bizamcer, A., Wyatt, S., Tonelli, M., Smelson, D. Co-Occurring Addiction and Psychotic Disorders. In A. Herron, T. Koehler Brennan (eds.). The ASAM Essentials of Addiction Medicine, 2nd edition.  Philadelphia, PA: Wolters Kluwer. 505-511, 2015.

 35.  Ziedonis, D., Cimpeanu, C., Tonelli, M.  Substance-Related and Addictive Disorders: Tobacco-Related Disorders. In A. Tasman, J. Kay, J.A. Lieberman, M.B. First, M.B. Riba (eds.). Psychiatry, Volume 2, 4th Edition. Wiley-Blackwell. pp. 1615-1637, 2015.

 36.  Kalman, D., Harrington, A., DiFranza, J., Pbert, L., and Ziedonis, D. M. Nicotine Dependence. In A. Mack, R. Frances, K. Brady, S. Miller (eds). Clinical Textbook of Addictive Disorders, 4th Edition. New York, NY: Guilford Publications, Inc., 2016.

 37.  Ziedonis, D, Tonelli, M, Das, S. Tobacco-Related Disorder. In B. Sadock, V. Sadock, P. Ruiz (eds.). Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 10th edition. (2017).

 38.  Ziedonis, D.M., Fan, X., Larkin, C., Wyatt, S., Smelson, D. Co-Occurring Addiction and Psychotic Disorders. In Miller,S.C. Fiellin, D.A., Rosenthal, R.N., and Saitz. R. (eds.). The ASAM Principles of Addiction Medicine, 6th edition.  Philadelphia, PA: Wolters Kluwer. (2018)

 39.  Ziedonis, D.M. and Iflund, J. Introductions to Recovery from Processed Food Addiction. In: Ifland, J., Marcus, M.T., Preuss, H.G. (eds.) Processed Food Addiction: Foundations, Assessment, and Recovery. CRC Press, Boca Raton, FL, 307-320, 2018.

 40.  Ziedonis, D.M. and Iflund, J. Premises of Recovery for Adults. In: Ifland, J., Marcus, M.T., Preuss, H.G. (eds.)Processed Food Addiction: Foundations, Assessment, and Recovery. CRC Press, Boca Raton, FL, 321-340, 2018.

 41.  Ziedonis, D.M. and Iflund, J. Avenues to Success for the Practitioner. In: Ifland, J., Marcus, M.T., Preuss, H.G. (eds.).  Processed Food Addiction: Foundations, Assessment, and Recovery. CRC Press, Boca Raton, FL, 341-353, 2018.

 42.  Ziedonis D., Larkin, C., Fan, X, Wyatt, S.A., Smelson, D. Co-occurring addiction and psychotic disorders. In Essentials of Addiction Medicine 3rd Ed. Eds. Herron, A., Brennan, T. Philadelphia: Wolters Kluwer Health. 2019.    

 43.  Lenroot RK, Maviglia MA, Tai-Seale M, Ziedonis DM.  Open Dialogue approach to treating serious mental illness.  Chapter 26.  Research Handbook on Society and Mental Health. Edward Elgar Publishing. Editor, Marta Elliott. 461-481, 2022. 

 44.  Ziedonis D, Cimpeanu, Bachyrycz, Morelli E, and Rancans E..   Disorders Due to Substance Use:  Nicotine (Including Tobacco and Vaping).  Tasman’s Psychiatry.  Springer Nature Switzerland AG.  Editors: Tasman A. et al. https://doi.org/10.1007/978-3-030-42825-9_13-1   (55 pages).  First online:  July 2023.

 45.  Ziedonis D, Fan X, Bhatt S, and Wyatt S.  Chapter 103.  Co-Occurring Substance Use Disorders and Psychosis. The ASAM Principles of Addiction Medicine 7th Edition: Print + eBook with Multimedia.  Editor Miller SC et al. (22 pages). 2024

 46.  Das S, Isakson B, and Ziedonis.  Chapter 11.8.  Tobacco-Related Disorders.  Kaplan and Sadocks Comprehensive Textbook of Psychiatry, 11e. Editors:  Boland RL and Verduin M. 1382-1394.  2025. 

 Behavioral Therapy Manuals:

1.     Ziedonis, D.M. and D’Avanzo, K. Dual Recovery Therapy for Schizophrenia and Cocaine Addiction. National Institute of Drug Abuse Behavioral Therapy Development Study Manual. Yale University. New Haven CT. 1998.

 2.     Ziedonis, D.M. and Krejci, J. Dual Recovery Therapy: Supporting Integrated Recovery from Co-occurring Substance Abuse and Mental Disorders in Outpatient Substance Abuse Treatment Settings. Substance Abuse Mental Health Service Agency (SAMHSA). UMDNJ. Piscataway NJ. 2004

 3.     Krejci, J.A., Steinberg, M.L. and Ziedonis, D.M. Motivational interviewing in tobacco dependence Manual. NIDA Behavioral Therapy Development Study Manual. UMDNJ. Piscataway NJ. 2004

 4.     Krejci, J.A. and Ziedonis, D.M. Adapting Motivational Enhancement Therapy for Poly-Drug Addiction: A Therapist Manual for Addiction Counselors.  NIDA Behavioral Therapy Development Study Manual.    UMDNJ. Piscataway NJ. 2004

 5.     Smelson, D., Kline, A., Hills, S., Ziedonis, D. The MISSION Treatment Manual. Substance Abuse and Mental Health Service Administration. (2007). http://www.missionmodel.org/manuals-1/

 6.     Williams, J., Ziedonis, D.M., Krejci, J.A., Steinberg, M.L., and Zimmerman, M.  Medication Management For Schizophrenia and Tobacco Dependence. NIDA Behavioral Therapy Development Study Manual.  UMDNJ. Piscataway NJ. 2005

 7.     Ziedonis, D.M., Krejci, J.A., Steinberg, M.L., and Williams, J.M.  Treatment of Addiction to Nicotine In Schizophrenia: A Tobacco Dependence Treatment Manual for Therapists.  NIDA Behavioral Therapy Development Study Manual.  UMDNJ. Piscataway, NJ 2005

 8.     Ziedonis, D.M., Krejci, J.A., O’Hea, E.L., and Boudreaux, E.D. Motivation-Based Recovery Oriented Therapy: A Therapist Manual for Addiction Counselors Treating Poly-drug Addiction. NIDA Behavioral Therapy Development Study Manual.  UMDNJ. Piscataway NJ.   2005

 9.     Fortuna, LR, Jankowski, MK, Rosenberg, H, Mueser, K, Vallejo, Z, Rosenberg, S, Ziedonis, D. Cognitive Behavioral Therapy Integrated for PTSD and Substance Abuse for Adolescents NIDA Behavioral Therapy Development Study Manual.  University of Massachusetts Medical School, Worcester MA. 2010

 10.  Kelly M, Ziedonis D. Acceptance and Commitment Therapy for PTSD and Tobacco Addiction Treatment Manual. Veterans Health Administration Behavioral Therapy Development Study.VISN1. Bedford, MA. 2010

 11.  Smelson, D., Sawh, L, Kane, V., Kuhn, J, Ziedonis, D. The MISSION Treatment Manual: Veterans Edition. Veterans Health Administration. (2011). http://www.missionmodel.org/manuals-1/

 12.  Williams, J., Ziedonis, D., Speelman, N., Vreeland, B., Zechner, M.R., Rahim, R., O’Hea, E.L.  Learning About Healthy Living.  Tobacco and You.  New Jersey Division of Mental Health Services.  2005. (edited and revised, 2012)   http://www.njchoices.org/LAHL/2012%20lahl.pdf

 13.  Smelson, D., Sawh, L, Harter, J., Siegfriedt, J., & Ziedonis, D. The MISSION Treatment Manual: Second Edition. University of Massachusetts Medical School. (2014). http://www.missionmodel.org/manuals-1/

 14.  Smelson, D., Sawh, L., Harter, J., & Ziedonis, D. The MISSION Participant Workbook Second Edition. Substance Abuse and Mental Health Service Administration. (2014). http://www.missionmodel.org/manuals-1/

 15.  Pinals, D., Smelson, D., Sawh, L., Harter, J., & Ziedonis, D. The MISSION Criminal Justice Treatment Manual. University of Massachusetts Medical School. (2014). http://www.missionmodel.org/manuals-1/

 16.  Smelson, D., Pinals, D. Harter, J., Sawh, L., & Ziedonis, D. The MISSION Criminal Justice Participant Workbook. Substance Abuse and Mental Health Service Administration. (2014). http://www.missionmodel.org/manuals-1/

 17.  Smelson, D., Sawh, L., Harter, J., & Ziedonis, D. The MISSION Participant Workbook Second Edition, Spanish Edition. Substance Abuse and Mental Health Service Administration. (2014). http://www.missionmodel.org/manuals-1/

 18.  Olson M, Seikkula J, and Ziedonis D.   The Key Elements of Dialogic Practice in Open Dialogue: Fidelity Criteria. University of Massachusetts Medical School. (available online since 2014). www.umassmed.edu/globalassets/psychiatry/opendialogue/keyelementsv1.109022014.pdf

 19.  Smelson, D., Sawh, L., Harter, J., & Ziedonis, D. The MISSION Participant Workbook Second Edition, Spanish Edition. Substance Abuse and Mental Health Service Administration. (2015). http://www.missionmodel.org/manuals-1/

 20.  Smelson, D., Pinals, D., Harter, J., Sawh, L., and Ziedonis, D. The MISSION Criminal Justice Treatment Manual, Spanish Edition. Substance Abuse and Mental Health Service Administration. (2015).       http://www.missionmodel.org/manuals-1/

 Organizational Change & Leadership Development Manuals

 1.     Ziedonis, D.M., Comerford, T., Violette, N., and Krejci, J. Addressing Mental Health Problems in Substance Abuse Treatment: A Guide to Developing Consultant-Integrated and Fully-Integrated Programs Manual.  Substance Abuse and Mental Health Service Administration (SAMHSA). UMDNJ. Piscataway NJ. 2004.

 2.     Ziedonis, D.M. and Krejci, J. Addressing Mental Health Problems in Substance Abuse Treatment: A Guide to Assessment and Treatment Planning for Substance Abuse Counselors - Clinician Guide. Substance Abuse and Mental Health Service Administration (SAMHSA). UMDNJ. Piscataway, NJ.  2004.

   3.     Ziedonis, D.M. and Krejci, J. Addressing Mental Health Problems in Substance Abuse Treatment: A Guide to Assessment and Treatment Planning for Substance Abuse Counselors - Instructor Guide. Substance Abuse and Mental Health Service Administration (SAMHSA). UMDNJ. Piscataway, NJ. 2004.

 4.     Ziedonis, D.M. and Krejci, J. Addressing Mental Health Problems in Substance Abuse Treatment: A Guide to Assessment and Treatment Planning for Substance Abuse Counselors - Self-study Clinician Guide. Substance Abuse and Mental Health Service Administration (SAMHSA).  UMDNJ. Piscataway, NJ. 2004.

 5.     Ziedonis, D.M. and Krejci, J. A Guide for Supervisors of Substance Abuse Counselors Using the Self-Study Clinician Guide.  Substance Abuse and Mental Health Service Administration (SAMHSA). UMDNJ. Piscataway NJ 2004 

 6.     Ziedonis DM, et al.  Addressing Tobacco Through Organizational Change. NIDA Organizational Change Study Manual.  University of Massachusetts. Worcester MA. 2011.

 7.     McKay, C., Ziedonis, D., Seward, G., Bradley, K. Sawyer, E., Williams, V., Adams, J., Letourneau, P., Rocheleau, D., & Perkins, L. Promoting Healthy Lifestyles Clubhouse Toolkit. Legacy Foundation. The University of Massachusetts Medical School: Worcester, MA.  1-280.  2011.

 8.     Ziedonis D, Olson M, & Seikkula.  Adapting Open Dialogue & Dialogic Practice: Organizational & Therapeutic Methods and Fidelity Criteria Manual.  Foundation for Excellence in Mental Health Care.  2015

 9.     Ziedonis D & Lorberg B.  Mindful Physician Leadership Program Introductory Curriculum Guidebook. Physician’s Foundation.  The University of Massachusetts Medical School: Worcester, MA.  2018.

 10.  Ziedonis D & Lorberg B.  Mindful Physician Leadership Program Foundational Level Guidebook.  Physician’s Foundation.  The University of Massachusetts Medical School: Worcester, MA.  2018.

 11.  Ziedonis D & Lorberg B.  Mindful Physician Leadership Program Teleconference Call Group Guidebook. Physician’s Foundation.  The University of Massachusetts Medical School: Worcester, MA.  2018.  

 12.  Ziedonis D & Lorberg B.  Mindful Physician Leadership Program Advanced Level Guidebook. Physician’s Foundation.  The University of Massachusetts Medical School: Worcester, MA.  2018.  

 Refereed Published Conference Proceedings (NIDA Research Monograph Series & Journals): 

 1.     Ziedonis D and Kosten T.  Depression as a Treatment Matching Factor in Cocaine Dependence Treatment. .  In Harris editor, Problems of Drug Dependence 1991. NIDA Research Monograph Series. DHHS Washington D.C.; USGPO. 1992: (119), 365.

2.     Kosten T, Schottenfeld RS, Morgan CH, Falcioni J, and Ziedonis D.  Buprenorphine vs. Methadone for Opioid and Cocaine Dependence. In Harris editor Problems of Drug Dependence 1991.  NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1992: (119), 359. 

3.     Margolin A, Avants SK, Ziedonis D, Petrakis I, and Kosten TR.   Pre- and Post-Treatment Cue-Reactivity in Cocaine Addicts Treated with Bupropion. In Harris editor Problems of Drug Dependence 1991. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1992: (119), 463.

4.     Ziedonis, D.M., Kosten, T.R., Glazer, W. The impact of drug abuse on psychopathology and movement disorders in chronic psychotic outpatients.  In Harris editor, Problems of Drug Dependence 1992.  NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1993: (132), 153.

 5.     Schottenfeld, R.S., Ziedonis, D., Pakes, J., Kosten, T.R. Buprenorphine dose ranging for combined cocaine and opiate dependence. In Harris editor, Problems of Drug Dependence 1992. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1993. (132), 311.

 6.     Kosten, T.R., Schottenfeld, R.S., Ziedonis, D.M., Falcioni, J. Six month trial of buprenorphine versus methadone for opioid use. .  In Harris editor Problems of Drug Dependence 1992.  NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1993. (132), 100.

 7.     Schottenfeld RS, Kosten TR, Pakes J, Ziedonis D, and Oliveto A.  Buprenorphine versus Methadone Maintenance for Combined Cocaine and Opioid Dependence. In Harris editor Problems of Drug Dependence 1993, Vol II.   NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1994 (141), 142.

 8.     Ziedonis DM, Kosten T, and Glazer W.  Nicotine Dependence and Schizophrenia: The Relationship to Psychopathology and Neuroleptic Medication Dosage and Side Effects. Problems of Drug Dependence 1993, Vol II.  NIDA Research Monograph DHHS Washington D.C.; USGPO.1994 (141).  236.

 9.     Leal J, Ziedonis D, and Kosten T.  The Prognostic Significance of Antisocial Personality Disorder in the Treatment of Cocaine Dependence Using Pharmacotherapy.  Problems of Drug Dependence of 1993. Vol II. NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1994. (141), 434.

 10.  Sikowitz D, Ziedonis DM, Hayes M, and Kosten T. Prolonged Adjunctive Clonidine Usage Improves Treatment Outcomes for Opioid Addicts Given Naltrexone. Problems of Drug Dependence of 1993. Vol II.  NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1994. (141), 452.

11.  Oliveto A, Kosten TR, Schottenfeld R, and Ziedonis D.  Effects of Desipramine, Amantadine, or Fluoxetine on Cocaine and Opioid Use in Buprenorphine-Maintained Patients: A Pilot Study. Problems of Drug Dependence 1994.    NIDA Research Monograph Series. DHHS Washington D.C.; USGPO. 1995 (153) 25.

12.  Gill TS, Ziedonis DM, Farren CK, Wallace EA, and Schottenfeld RS. A Survey of Sleep Problems in a Substance Abuse Population. In Harris editor, Problems of Drug Dependence 1994.  NIDA Research Monograph Series.  DHHS Washington D.C.; USGPO.1995 (153) 100.

 13.  Ziedonis DM, Farren C, and Kosten TR.  Depression in Cocaine Abusing Opioid Addicts Treated with Either Buprenorphine or Methadone. In Harris editor, Problems of Drug Dependence 1994. NIDA Research Monograph Series.  DHHS Washington D.C.; USGPO.1995 (153) 211.

 14.  Farren CK, McDougle C, Price L, Ziedonis D, Hameedi F, and Kosten T.  Growth Hormone Responses to Dopamine Antagonists in Cocaine Addicts and Alcoholics. In Harris editor,  Problems of Drug Dependence 1994. NIDA Research Monograph Series.  1995 (153) 323.

 15.   Ziedonis D, Fisher W, Harris P, Trudeau K, Rao S, and Kosten T. Adjunctive Selegiline in the Treatment of Cocaine Abusing Schizophrenics. In Harris editor, Problems of Drug Dependence 1995.  NIDA Research Monograph Series, DHHS Washington D.C.; USGPO.1996. (162), 325. 

 16.  Ziedonis D; D’Avanzo K; Kasuba B; Cosentino W, Trudeau K, Harris P, and Harmon L. Dual Diagnosis Relapse Prevention (DDRP): A Preliminary Outcome Report. In Harris editor, Problems of Drug Dependence 1996.    NIDA Research Monograph Series. DHHS Washington D.C.; USGPO. 1997 (174) 127.

17.  Smelson, D., Roy, M., Roy, A., Harter, J., Engelhart, C., & Ziedonis, D. Relationship between the electroretinogram blue cone amplitude and cue-eliciting cocaine craving.  In Harris editor, College of Problems of Drug Dependence, 1999.  National Institute of Drug Abuse Research Monograph. DHHS Washington D.C.; USGPO. 2000.

 18.  Mordan, E., Weeks, A., Geffrard, M., Baumann, B.M., Camargo, C.A., Jr., Ziedonis, D.M., Boudreaux, E.D. Expired carbon monoxide validation of self-reported smoking among ED patients. Academic Emergency Medicine 12(5):45, 2005.

 19.  Boudreaux, E.D., Baumann, B.M., Camargo, C.A., Foulds, J., Ziedonis, D.M. Smoking among adult emergency department patients: Abstinence and stage of change one month post-visit. Annals of Behavioral Medicine 29S:29, 2005.

 20.  Boudreaux, E.D., Baumann, B.M., Foulds, J., Camargo, C.A. Jr., Perry, J., Ziedonis, D.M.  An exploratory study of ED-initiated tobacco interventions: Deriving parameter estimates to plan randomized trials.  Academic Emergency Medicine S309, 2006.

 21.  Boudreaux, E.D., Baumann, B.M., Foulds, J. Camargo, C.A., Jr., Ziedonis, D.  The effect of removing cost as a barrier to treatment initiation with an outpatient tobacco dependence clinic among emergency department patients.  Academic Emergency Medicine 13:S373, 2006.

 22.  Boudreaux, E.D., Baumann, B., Perry, J., Marks, D., Francies S., Velazaquez, M., Reinglass, A, Camargo, C., Ziedonis, D. Emergency department initiated tobacco interventions. Annals of Behavioral Medicine, 33:S098, 2007.

 23.  Boudreaux, E.D., Baumann, B.M., Marks, D., Francies, S., Ziedonis, D.  Polysubstance abuse, readiness to quit, and interest in ED-initiated interventions among adult emergency department patients.  Academic Emergency Medicine, 2008. 15:S166.

 24.  Haskins B, Le R, Terrian L, Grissom G, Ziedonis D, Boudreaux ED. Evaluation of websites and web-based applications targeting alcohol and drug use. Annals of Behavioral Medicine, 2014; 47: s139.

 25.  Murphy KM & Ziedonis DM. Group Guided Imagery and Music for Adults in Addiction Treatment: A Pilot Randomized Control Trial Feasibility Study.  Research Symposium Proceedings: 24th International Association      for Music & Imagery Conference. 2017; 19-22.

 OTHER WORK

 Music CD

 1.     Ziedonis, D.M. and Clottey, K. The Journey.  Mindfulness Music. (www.cdbaby.com/cd/ziedonis). World Music – Native American Flute, African Hand drums, Balafon, and Latvian Kokle.   2004.

 Computer Programs

 1.     Krejci, J.A., Steinberg, M.L. and Ziedonis, D.M. Motivating Ambivalent Smokers to Quit (MASQ) for MS Excel 97 [computer program].  Piscataway, NJ, University of Medicine and Dentistry of New Jersey/ Robert Wood Johnson Medical School. 2001.

 2.     Steinberg, M.L., Krejci, J.A., Ziedonis, D.M., and Williams, J.M. A Personalized Assessment Feedback Report for Smokers with Schizophrenia for MS Excel and MS Word [computer program].  Piscataway, NJ, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Division of Addiction Psychiatry. 2003. 

 Video Products:

 1.     Hall, W. C., Anderson, M. L., Elliott, M. E., & Ziedonis, D. M. (2014). Engaging the deaf community in behavioral health research: Insider, outsider, and ally perspectives. Available at https://youtu.be/jr1IlMZb55I

 Summary: 345 publications / scholarly works:  

With 158 original research articles, 3 major reviews (NIH, IOM, RCP), 6 practice guidelines, 37 review articles, 1 letter, 24 invited articles, 9 books, 46 chapters, 20 behavioral therapy manuals, 12 organizational change & leadership development manuals, 25 refereed published conference proceedings (NIDA Research Monograph Series & Journals), 1 CD, 2 computer programs, and 1 video